Published in Am J Obstet Gynecol on March 01, 2007
Serum microRNAs are promising novel biomarkers. PLoS One (2008) 8.69
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther (2007) 3.93
Plasma components affect accuracy of circulating cancer-related microRNA quantitation. J Mol Diagn (2011) 2.57
Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol (2008) 2.30
MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle (2010) 2.18
Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med (2008) 1.93
MiR-210--micromanager of the hypoxia pathway. Trends Mol Med (2010) 1.90
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood (2013) 1.87
Epigenetics in the placenta. Am J Reprod Immunol (2009) 1.77
Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (2010) 1.52
Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer (2010) 1.46
Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci (2010) 1.45
Epigenetics and lifestyle. Epigenomics (2011) 1.34
From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges. Nat Med (2012) 1.34
A comprehensive survey of miRNA repertoire and 3' addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing. PLoS One (2011) 1.26
MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta (2012) 1.26
miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS One (2011) 1.17
Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics (2010) 1.17
Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab (2012) 1.15
Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med (2011) 1.13
The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol (2013) 1.12
miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies. Am J Pathol (2011) 1.06
Differential expression of microRNAs with progression of gestation and inflammation in the human chorioamniotic membranes. Am J Obstet Gynecol (2007) 1.06
Gene expression in the placenta: maternal stress and epigenetic responses. Int J Dev Biol (2010) 1.02
Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem (2012) 1.01
Expression patterns of microRNAs in the chorioamniotic membranes: a role for microRNAs in human pregnancy and parturition. J Pathol (2009) 1.01
Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition. Semin Reprod Med (2011) 1.01
MicroRNAs in skin and wound healing. Physiol Genomics (2010) 1.00
MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci (2013) 1.00
miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol (2013) 0.98
Downregulated miR-195 detected in preeclamptic placenta affects trophoblast cell invasion via modulating ActRIIA expression. PLoS One (2012) 0.95
miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoS One (2012) 0.95
Differential miRNA expression profiles between the first and third trimester human placentas. Am J Physiol Endocrinol Metab (2013) 0.95
miR-210: fine-tuning the hypoxic response. Adv Exp Med Biol (2014) 0.95
Little but loud: small RNAs have a resounding affect on ear development. Brain Res (2009) 0.94
Human placental microRNAs and preeclampsia. Biol Reprod (2013) 0.94
Prediction of preeclampsia - a workshop report. Placenta (2007) 0.93
Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int (2013) 0.93
Minireview: The roles of small RNA pathways in reproductive medicine. Mol Endocrinol (2011) 0.92
The unique expression and function of miR-424 in human placental trophoblasts. Biol Reprod (2013) 0.91
Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci Rep (2014) 0.90
TLR3-induced placental miR-210 down-regulates the STAT6/interleukin-4 pathway. PLoS One (2013) 0.89
Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens (2012) 0.88
MicroRNAs and esophageal cancer. J Gastrointest Oncol (2010) 0.88
Trophoblasts, invasion, and microRNA. Front Genet (2013) 0.88
miR455 is linked to hypoxia signaling and is deregulated in preeclampsia. Cell Death Dis (2014) 0.87
Circulating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction. Mediators Inflamm (2013) 0.87
Hypoxamirs and mitochondrial metabolism. Antioxid Redox Signal (2014) 0.86
Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity. Int J Obes (Lond) (2015) 0.86
Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. Int J Biol Sci (2014) 0.85
Identification of microRNAs that regulate TLR2-mediated trophoblast apoptosis and inhibition of IL-6 mRNA. PLoS One (2013) 0.85
Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS One (2013) 0.85
Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr Res (2013) 0.85
MicroRNAs in placental health and disease. Am J Obstet Gynecol (2015) 0.85
Exposure and fetal growth-associated miRNA alterations in the human placenta. Clin Epigenetics (2011) 0.84
Aberrant upregulation of miR-21 in placental tissues of macrosomia. J Perinatol (2014) 0.84
Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS One (2014) 0.84
Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications. Biomed Res Int (2015) 0.84
OxymiRs in cutaneous development, wound repair and regeneration. Semin Cell Dev Biol (2012) 0.83
Combined Screening for Early Detection of Pre-Eclampsia. Int J Mol Sci (2015) 0.83
Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency. DNA Cell Biol (2012) 0.82
Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int (2015) 0.82
Gestational tissue transcriptomics in term and preterm human pregnancies: a systematic review and meta-analysis. BMC Med Genomics (2015) 0.81
miR-143 regulation of prostaglandin-endoperoxidase synthase 2 in the amnion: implications for human parturition at term. PLoS One (2011) 0.81
Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A. Sci Rep (2016) 0.81
Characterization and predicted role of the microRNA expression profile in amnion from obese pregnant women. Int J Obes (Lond) (2013) 0.80
Pathogenesis and promising non-invasive markers for preeclampsia. Obstet Gynecol Sci (2013) 0.80
First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension. PLoS One (2014) 0.80
Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the Disease. PLoS One (2016) 0.79
MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia. J Hum Hypertens (2014) 0.79
Primate-specific miR-515 family members inhibit key genes in human trophoblast differentiation and are upregulated in preeclampsia. Proc Natl Acad Sci U S A (2016) 0.79
Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice. PLoS One (2015) 0.78
Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies. Front Physiol (2016) 0.78
Quantification of preeclampsia-related microRNAs in maternal serum. Biomed Rep (2015) 0.78
The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signaling. Sci Rep (2016) 0.78
Mechanisms and therapeutic potential of microRNAs in hypertension. Drug Discov Today (2015) 0.78
miR-125b Enhances IL-8 Production in Early-Onset Severe Preeclampsia by Targeting Sphingosine-1-Phosphate Lyase 1. PLoS One (2016) 0.78
Circulating MicroRNAs as Potential Molecular Biomarkers in Pathophysiological Evolution of Pregnancy. Dis Markers (2016) 0.77
Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications. DNA Cell Biol (2015) 0.77
Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia. PLoS One (2015) 0.77
Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. Mol Hum Reprod (2016) 0.77
FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia. Sci Rep (2017) 0.76
Involvement of miRNAs in placental alterations mediated by oxidative stress. Oxid Med Cell Longev (2014) 0.76
Predictive value of miR-210 as a novel biomarker for pre-eclampsia: a systematic review protocol. BMJ Open (2016) 0.76
The Effect of an Obesogenic Maternal Environment on Expression of Fetal Umbilical Cord Blood miRNA. Reprod Sci (2014) 0.76
Placental Epigenetics in Children's Environmental Health. Semin Reprod Med (2015) 0.76
AngiomiRs: Potential Biomarkers of Pregnancy's Vascular Pathologies. J Pregnancy (2015) 0.76
Expression patterns of WRKY genes in di-haploid Populus simonii × P. nigra in response to salinity stress revealed by quantitative real-time PCR and RNA sequencing. Plant Cell Rep (2014) 0.76
MicroRNAs of Toxocara canis and their predicted functional roles. Parasit Vectors (2016) 0.76
MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma. J Cancer (2015) 0.75
Placental microRNA Expression Is Not Altered by Maternal Obesity and Fetal Overgrowth. AJP Rep (2016) 0.75
Placental microRNA expression in pregnancies complicated by superimposed pre‑eclampsia on chronic hypertension. Mol Med Rep (2016) 0.75
Analysis of circulating human and viral microRNAs in patients with congenital cytomegalovirus infection. J Perinatol (2016) 0.75
Expression and significance of miR155 and vascular endothelial growth factor in placenta of rats with preeclampsia. Int J Clin Exp Med (2015) 0.75
Do miRNAs Play a Role in Fetal Growth Restriction? A Fresh Look to a Busy Corner. Biomed Res Int (2017) 0.75
Dysregulated circulating miRNAs in preeclampsia. Biomed Rep (2016) 0.75
Cross Talk between Adipose Tissue and Placenta in Obese and Gestational Diabetes Mellitus Pregnancies via Exosomes. Front Endocrinol (Lausanne) (2017) 0.75
Investigating causal relation between prenatal arsenic exposure and birthweight: Are smaller infants more susceptible? Environ Int (2017) 0.75
Epidemiology and causes of preterm birth. Lancet (2008) 18.96
Profiling gene expression using onto-express. Genomics (2002) 12.65
Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res (2004) 12.19
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
A systems biology approach for pathway level analysis. Genome Res (2007) 6.95
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
A novel signaling pathway impact analysis. Bioinformatics (2008) 5.06
Use and misuse of the gene ontology annotations. Nat Rev Genet (2008) 5.01
Recent additions and improvements to the Onto-Tools. Nucleic Acids Res (2005) 3.88
The role of inflammation and infection in preterm birth. Semin Reprod Med (2007) 3.57
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39
Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01
Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2011) 2.95
Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet (2008) 2.90
NetPath: a public resource of curated signal transduction pathways. Genome Biol (2010) 2.62
Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med (2006) 2.59
Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57
Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2003) 2.55
Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev (2002) 2.42
The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 2.36
Onto-Tools: new additions and improvements in 2006. Nucleic Acids Res (2007) 2.33
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
Listeriosis in human pregnancy: a systematic review. J Perinat Med (2011) 2.20
The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol (2006) 2.11
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res (2006) 2.08
A semantic analysis of the annotations of the human genome. Bioinformatics (2005) 2.01
Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev (2007) 2.01
The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol (2010) 1.99
Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics (2002) 1.99
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med (2005) 1.99
Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci U S A (2006) 1.89
Genomics, biogeography, and the diversification of placental mammals. Proc Natl Acad Sci U S A (2007) 1.86
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84
A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med (2006) 1.82
MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res (2002) 1.82
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol (2004) 1.81
Infection and prematurity and the role of preventive strategies. Semin Neonatol (2002) 1.78
Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med (2010) 1.77
Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol (2010) 1.77
Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol (2009) 1.77
Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol (2010) 1.75
Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74
Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol (2006) 1.73
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Gene-centric genomewide association study via entropy. Genetics (2008) 1.68
Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.65
Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol (2004) 1.64
A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol (2005) 1.64
Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res (2002) 1.64
A survey of small RNAs in human sperm. Hum Reprod (2011) 1.62
Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med (2007) 1.62
Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol (2004) 1.60
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med (2008) 1.60
Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits. J Child Neurol (2009) 1.58
Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol (2002) 1.58
Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am J Obstet Gynecol (2006) 1.54
The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med (2009) 1.54
A systematic approach to the use of the multiplanar display in evaluation of abnormal vascular connections to the fetal heart using 4-dimensional ultrasonography. J Ultrasound Med (2007) 1.53